Cheyne Capital Management (UK) LLP
CIK
1390457
Location
LONDON, X0
Portfolio Value
Micro
$1,402,504
Diversification
Highly concentrated
Filing Date
Global Rank
#6,534
/ 7,317
▼ 558
Top Industry
Drug Manufacturers - General
52.1%
3Y Alpha vs SPY
+10.9%
Period ended 2 years ago
Filed Feb 12, 2024 · 2y
16 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+128.4%
SPY
+76.3%
Annualised alpha
+10.9%
Max drawdown
−20.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
11 positions · as of Dec 31, 2023 · Δ vs Sep 30, 2023Top Position
52.1%
+16.4 pts
Top 5
81.5%
+8.1 pts
Top 10
99.2%
+8.2 pts
HHI
3,013
Highly concentrated+1,216
Portfolio Trend
16 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 52.1% | $11,748,169 |
| Energy | 38.7% | $8,721,985 |
| Basic Materials | 6.2% | $1,402,504 |
| Consumer Defensive | 2.2% | $502,810 |
| Communication Services | 0.8% | $170,700 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OXY | Occidental Petroleum Corp /De/ | −26,750 | 26,750 | $1,597,242 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| S | SentinelOne, Inc. | 266,700 | $4,496,562 | |
| IQV | Iqvia Holdings Inc. | 4,800 | $944,400 | |
| UBER | Uber Technologies, Inc | 20,000 | $919,800 | |
| CRL | Charles River Laboratories International, Inc. | 2,500 | $489,950 | |
| TVTX | Travere Therapeutics, Inc. | 26,200 | $234,228 | |
| No positions match the current search. | ||||
2 positions ·
$1,402,504 total
· Basic Materials only
· as of Dec 31, 2023
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AEM |
Agnico Eagle Mines Ltd
Basic Materials
|
Held | 16,400 | $899,540 | 64.14% | |
| PAAS |
Pan American Silver Corp
Basic Materials
|
Held | 30,800 | $502,964 | 35.86% |